Development of sleep outcome measures for chronic inflammatory dermatoses: Focus on psoriatic disease - 22/08/19
Lourdes M. Perez-Chada, MD, MMSc, Brigham & Women’s Hospital, Department of Dermatology, Harvard Medical School, Boston, MA; Elizabeth B. Klerman, MD, MPH, Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women’s Hospital, Boston, MA; Jiayang Li, BS, Brigham & Women’s Hospital, Department of Dermatology, Harvard Medical School, Boston, MA; Alice B. Gottlieb, MD, PhD, Metropolitan Hospital, New York Medical College, Department of Dermatology, New York, NY; Joseph F. Merola, MD, MMSc, Brigham & Women’s Hospital, Department of Dermatology, Harvard Medical School, Boston, MA
Le texte complet de cet article est disponible en PDF.| Commercial support: None identified. |
Vol 81 - N° 4S1
P. AB45 - octobre 2019 Retour au numéro
Article précédent
- Development of a novel electronic application of the Psoriasis Area Severity Index (PASI)
- Development of the alopecia areata patient priority outcomes instrument, a new patient reported outcome measure
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?